Cell therapy weekly: First cell therapy from engineered pluripotent stem cell receives IND Member Exclusive US and Canada, Industry developments, Gene editing, Manufacturing & scale-up, FDA Cell therapy weekly: First cell therapy from engineered pluripotent stem cell receives IND RegMedNet Feb 07, 2019
Keeping patients safe from unproven cell therapies: an interview with the ISCT Presidential Task Force on the Use of Unproven and/or Unethical Cell and Gene Therapies Member Exclusive INTERVIEW Ethics & policy, Cell therapy Keeping patients safe from unproven cell therapies: an interview with the ISCT Presidential Task Force on the Use of Unproven and/or Unethical Cell and Gene Therapies RegMedNet Feb 05, 2019
Cell therapy weekly: Regulators approve autologous stem cell therapy for spinal cord injury in Japanese first Member Exclusive NEWS ROUND-UP Latest news & views, Ethics & policy, Asia and the rest of the world, Gene editing, Manufacturing & scale-up Cell therapy weekly: Regulators approve autologous stem cell therapy for spinal cord injury in Japanese first RegMedNet Jan 31, 2019
2019 co-located Phacilitate Leaders World and the World Stem Cell Summit in Miami solidified regenerative medicine as the future of healthcare US and Canada, Upcoming & past events 2019 co-located Phacilitate Leaders World and the World Stem Cell Summit in Miami solidified regenerative medicine as the future of healthcare RegMedNet Jan 30, 2019
Phacilitate Leaders World and World Stem Cell Summit 2019: daily updates Member Exclusive Latest news & views, US and Canada, Upcoming & past events, RegMedNet Phacilitate Leaders World and World Stem Cell Summit 2019: daily updates RegMedNet Jan 29, 2019
Cell therapy weekly: First stem cell drug application approved in China for Phase II clinical trial Member Exclusive NEWS ROUND-UP Latest news & views, US and Canada, Asia and the rest of the world, Cell therapy, Clinical trials, Industry developments Cell therapy weekly: First stem cell drug application approved in China for Phase II clinical trial RegMedNet Jan 24, 2019
Cell therapy weekly: FDA to add 50 additional reviewers, expecting 200 INDs a year by 2020 Member Exclusive Ethics & policy, Cell therapy, FDA Cell therapy weekly: FDA to add 50 additional reviewers, expecting 200 INDs a year by 2020 RegMedNet Jan 17, 2019
Cell therapy weekly: Fujifilm to pump JP¥10 billion into contract manufacturing Member Exclusive US and Canada, Asia and the rest of the world, Cell therapy, Industry developments, Basic research Cell therapy weekly: Fujifilm to pump JP¥10 billion into contract manufacturing RegMedNet Jan 10, 2019
Phacilitate Leaders World and World Stem Cell Summit 2019: editor’s picks Member Exclusive Upcoming & past events Phacilitate Leaders World and World Stem Cell Summit 2019: editor’s picks RegMedNet Jan 09, 2019
Emily Whitehead Foundation and Phacilitate to hold yacht party fundraiser at Phacilitate Leaders World in Miami Latest news & views, US and Canada, Upcoming & past events Emily Whitehead Foundation and Phacilitate to hold yacht party fundraiser at Phacilitate Leaders World in Miami RegMedNet Jan 07, 2019
The Glossary for Cell & Gene Therapy and Regenerative Medicine 2018 RegMedNet, Regenerative Medicine: the journal The Glossary for Cell & Gene Therapy and Regenerative Medicine 2018 RegMedNet Jan 07, 2019
Top 10 posts on RegMedNet in 2018 Ask the experts, Latest news & views, Cell therapy, Clinical trials, Upcoming & past events, MSCs, Disease modeling Top 10 posts on RegMedNet in 2018 RegMedNet Dec 18, 2018
Cell therapy special: best of 2018 NEWS ROUND-UP Latest news & views, US and Canada, UK and Europe, Asia and the rest of the world, Cell therapy, Gene editing Cell therapy special: best of 2018 RegMedNet Dec 13, 2018
Cell therapy weekly: £1.1million funding for new research into patient experience of cell therapy Member Exclusive Latest news & views, UK and Europe, Cell therapy, Gene editing, Manufacturing & scale-up, CAR-T Cell therapy weekly: £1.1million funding for new research into patient experience of cell therapy RegMedNet Dec 06, 2018
Mapping the stem cell ecosystem: an interview with Paul Knoepfler INTERVIEW US and Canada, Industry developments, Regenerative Medicine: the journal Mapping the stem cell ecosystem: an interview with Paul Knoepfler RegMedNet Dec 05, 2018
In focus: regenerative materials In focus, Manufacturing & scale-up, Basic research In focus: regenerative materials RegMedNet Nov 30, 2018
A peek behind the preprint: Carlos Diaz-Castillo on junk DNA in regeneration INTERVIEW LONGER READ Basic research A peek behind the preprint: Carlos Diaz-Castillo on junk DNA in regeneration RegMedNet Nov 30, 2018
Cell therapy weekly: Potential second pregnancy in CRISPR storm Member Exclusive NEWS ROUND-UP Latest news & views, Ethics & policy, Asia and the rest of the world, Cell therapy, Gene editing Cell therapy weekly: Potential second pregnancy in CRISPR storm RegMedNet Nov 29, 2018
CRISPR scientist claims to have made the world’s first gene edited babies Member Exclusive Latest news & views, Ethics & policy, Asia and the rest of the world, Gene editing, Basic research CRISPR scientist claims to have made the world’s first gene edited babies RegMedNet Nov 27, 2018
12 days of Christmas: win the new glossary! RegMedNet 12 days of Christmas: win the new glossary! RegMedNet Nov 27, 2018
Cell therapy weekly: First patient dosed in Phase III osteoarthritis trial Member Exclusive NEWS ROUND-UP Cell therapy, Clinical trials, Industry developments Cell therapy weekly: First patient dosed in Phase III osteoarthritis trial RegMedNet Nov 22, 2018
Cell therapy weekly: StemGenex receives warning letter from FDA over unapproved cell therapy and facility with “significant violations” Member Exclusive NEWS ROUND-UP Ethics & policy, Cell therapy, Clinical trials Cell therapy weekly: StemGenex receives warning letter from FDA over unapproved cell therapy and facility with “significant violations” RegMedNet Nov 15, 2018
Cell therapy weekly: Piero Anversa retractions trigger trial pause Member Exclusive NEWS ROUND-UP Latest news & views, Cell therapy, Clinical trials, Basic research Cell therapy weekly: Piero Anversa retractions trigger trial pause RegMedNet Nov 08, 2018
Developing a novel biphasic barrier membrane for guided tissue regeneration Member Exclusive INTERVIEW LONGER READ Basic research Developing a novel biphasic barrier membrane for guided tissue regeneration RegMedNet Nov 03, 2018
Award for Cultivating Excellence 2018: BellaSeno GmbH Basic research, RegMedNet Award for Cultivating Excellence Award for Cultivating Excellence 2018: BellaSeno GmbH RegMedNet Nov 02, 2018
